AN2 Therapeutics vs CellCentric
AN2 Therapeutics vs CellCentric, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: AN2 Therapeutics is on 46/100 and CellCentric on 60/100.
Where each one leads
AN2 Therapeutics
Leads on none of the measures we hold for both companies.
CellCentric
- our overall score: 60/100 against 46/100
- domain rating: 35/100 against 29/100
- funding raised: $375M against $132M
At a glance
| Measure | AN2 Therapeutics | CellCentric |
|---|---|---|
| What it is | Clinical-stage biopharmaceutical company developing novel boron-based small molecule therapeutics for rare infectious diseases and oncology. | A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma. |
| Category | Biotechnology, Pharmaceuticals, Healthcare, Drug Discovery | Biotechnology, Pharmaceuticals, Healthcare, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Biopharmaceutical | Services |
| Founded | 2018 | 2003 |
| Headquarters | Menlo Park, United States | Cambridge, United Kingdom |
| Status | Active | Active |
Size, funding and growth
| Measure | AN2 Therapeutics | CellCentric |
|---|---|---|
| Employees | Not published | 53 |
| Total funding | $132M | $375M |
| Latest round | Private Placement | Series D |
| Valuation | $1.1B | Not published |
| LinkedIn followers | Not published | 28,695 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | AN2 Therapeutics | CellCentric |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 46/100 | 60/100 |
| Traction | 40/100 | 57/100 |
| Team | 70/100 | 60/100 |
| Search visibility | 12/100 | 44/100 |
| Quality | 55/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (32/100) | F (32/100) |
| Domain ratingLink authority, 0-100 | 29/100 | 35/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | AN2 Therapeutics | CellCentric |
|---|---|---|
| Hosting | AWS | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Jquery | Jquery |
| Analytics | Google Analytics 4 | Google Analytics 4 |
AN2 Therapeutics vs CellCentric: common questions
Which is better, AN2 Therapeutics or CellCentric?
On our 0-100 score CellCentric rates higher (60/100 against 46/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do AN2 Therapeutics and CellCentric compare on the numbers?
CellCentric leads on our overall score (60/100 against 46/100), domain rating (35/100 against 29/100), funding raised ($375M against $132M).
Read the full AN2 Therapeutics review and pricing or the CellCentric review and pricing. You can also browse other AN2 Therapeutics alternatives we track.